| Detected | Trial | Change |
|---|---|---|
| 2026-08-09 | NCT05963347 Go-CHOP as the Frontline Therapy for PTCL |
overall status: Recruiting → Unknown |
| 2026-08-01 | NCT07629817 Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant… |
Recruitment opened |
| 2026-07-30 | NCT07459608 Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Mature B-cell… |
date change Primary completion pushed: 2027-01-01 -> 2027-07-01 |
| 2026-07-22 | NCT07559786 A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab… |
Recruitment opened |
| 2026-07-22 | NCT07559786 A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab… |
date change Primary completion pushed: 2029-04-01 -> 2029-07-17 |
| 2026-07-22 | NCT07559786 A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab… |
date change Completion pushed: 2029-04-01 -> 2029-07-17 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-11 | NCT07757022 AI-Driven Digital Twin and Drug Simulation for Esophageal Cancer | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06897917 | Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients… | Opioid-Induced Constipation | Not Yet Recruiting |
| Phase 3 | |||
| NCT04138212 | Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally… | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT04280822 | Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal… | Esophageal Cancer | Recruiting |
| NCT04547907 | A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early… | Breast Cancer,HER2-positive | Recruiting |
| NCT05495152 | Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT05063136 | Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast… | Breast Cancer | Recruiting |
| NCT07057427 | Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast… | Breast Cancer | Recruiting |
| NCT07629817 | Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant… | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT07332221 | Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A… | Esophageal Cancer | Not Yet Recruiting |
| Phase 2 | |||
| NCT05617859 | Lenvatinib for Advanced Bone and Soft Tissue Sarcoma | Effectiveness | Recruiting |
| NCT05377658 | AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell… | Non-small Cell Lung Cancer | Recruiting |
| NCT06293014 | TAS-102 Combined With Bevacizumab for Second-line Maintenance Treatment of Advanced… | Colorectal Cancer | Recruiting |
| NCT04891016 | Toripalimab Plus FLOT in Locally Advanced Gastric Cancer | Chemotherapy | Recruiting |
| NCT06176534 | Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With… | Advanced Breast Cancer | Recruiting |
| NCT06598046 | A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine… | Metastatic Breast Cancer | Recruiting |
| NCT05911958 | A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2… | HER2 Low Breast Carcinoma | Recruiting |
| NCT06276868 | Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of… | Breast Cancer | Recruiting |
| NCT06749730 | Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line… | Unresectable Biliary Tract Carcinoma | Recruiting |
| NCT06774222 | A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative… | Gastric/Gastroesophageal Junction Adenocarcinoma | Recruiting |
| NCT05918328 | Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of… | Breast Cancer | Recruiting |
| NCT04737889 | Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central… | Primary Central Nervous System Lymphoma | Recruiting |
| NCT05209620 | Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System… | Central Nervous System Lymphoma | Recruiting |
| NCT06945705 | A Clinical Trial of Furmonertinib Combined With Anlotinib as First-line Treatment for… | NSCLC | Recruiting |
| NCT06860529 | Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer | HR+/HER2- Breast Cancer | Recruiting |
| NCT06927180 | SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Recruiting |